Virtu Financial LLC Tricida, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.56 - $4.64 $38,893 - $50,692	-10,925 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$3.95 - $5.41 $43,153 - $59,104	10,925 New	10,925 $47,000
Q1 2021 May 19, 2021	SELL	$4.52 - $7.8 $109,903 - $189,657	-24,315 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$4.37 - $9.46 $106,256 - $230,019	24,315 New	24,315 $171,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.